Despite numerous scientific, ethical and methodological challenges, microbicides provide real potential to influence the course of the HIV epidemic as they could fill an important gap for women-initiated prevention methods
ABSTRACT Vaginal HIV microbicides offer great promise in preventing HIV transmission, but failures o...
Microbicides are chemical agents used topically by women within the vagina in order to prevent infec...
After two decades of microbicide clinical trials it remains uncertain if vaginally- delivered produc...
BACKGROUND: With 2.5 million new HIV infections per year, effective preventive methods against HIV a...
Results of the HPTN 035 trial. Abstract 48LB (16th Conference on Retroviruses and Opportunistic Infe...
OBJECTIVE: To determine the safety and effectiveness of BufferGel and 0.5% PRO2000 microbicide gels ...
BACKGROUND: Each year more than two million people are newly infected with HIV worldwide, a majority...
Background With 2.5 million new HIV infections per year, effective preventive methods against HIV ar...
BACKGROUND: Innovative prevention strategies for HIV-1 transmission are urgently needed. PRO2000 vag...
Low adherence in vaginal microbicide clinical trials for HIV prevention has impeded interpretation o...
Background: The majority of new HIV infections are acquired through heterosexual transmission. There...
Human immunodeficiency virus (HIV) is transmitted predominantly through sexual intercourse. Research...
To assess the views of potential end-users of a microbicide in KwaZulu-Natal regarding the character...
In preparation for effectiveness trials of candidate vaginal microbicides, scientists are debating t...
Vaginal HIV microbicides offer great promise in preventing HIV transmission, but failures of phase 3...
ABSTRACT Vaginal HIV microbicides offer great promise in preventing HIV transmission, but failures o...
Microbicides are chemical agents used topically by women within the vagina in order to prevent infec...
After two decades of microbicide clinical trials it remains uncertain if vaginally- delivered produc...
BACKGROUND: With 2.5 million new HIV infections per year, effective preventive methods against HIV a...
Results of the HPTN 035 trial. Abstract 48LB (16th Conference on Retroviruses and Opportunistic Infe...
OBJECTIVE: To determine the safety and effectiveness of BufferGel and 0.5% PRO2000 microbicide gels ...
BACKGROUND: Each year more than two million people are newly infected with HIV worldwide, a majority...
Background With 2.5 million new HIV infections per year, effective preventive methods against HIV ar...
BACKGROUND: Innovative prevention strategies for HIV-1 transmission are urgently needed. PRO2000 vag...
Low adherence in vaginal microbicide clinical trials for HIV prevention has impeded interpretation o...
Background: The majority of new HIV infections are acquired through heterosexual transmission. There...
Human immunodeficiency virus (HIV) is transmitted predominantly through sexual intercourse. Research...
To assess the views of potential end-users of a microbicide in KwaZulu-Natal regarding the character...
In preparation for effectiveness trials of candidate vaginal microbicides, scientists are debating t...
Vaginal HIV microbicides offer great promise in preventing HIV transmission, but failures of phase 3...
ABSTRACT Vaginal HIV microbicides offer great promise in preventing HIV transmission, but failures o...
Microbicides are chemical agents used topically by women within the vagina in order to prevent infec...
After two decades of microbicide clinical trials it remains uncertain if vaginally- delivered produc...
DOI
Add to ORKG